ATE231614T1 - Screening-test für kalium-kanal agonisten - Google Patents
Screening-test für kalium-kanal agonistenInfo
- Publication number
- ATE231614T1 ATE231614T1 AT96933513T AT96933513T ATE231614T1 AT E231614 T1 ATE231614 T1 AT E231614T1 AT 96933513 T AT96933513 T AT 96933513T AT 96933513 T AT96933513 T AT 96933513T AT E231614 T1 ATE231614 T1 AT E231614T1
- Authority
- AT
- Austria
- Prior art keywords
- potassium channel
- screening test
- channel agonists
- test substance
- test
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/10—Screening for compounds of potential therapeutic value involving cells
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Pathology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Cosmetics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Crystals, And After-Treatments Of Crystals (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9520411.1A GB9520411D0 (en) | 1995-10-06 | 1995-10-06 | Method of testing |
PCT/GB1996/002442 WO1997014036A1 (en) | 1995-10-06 | 1996-10-04 | Screening assay for k+ channel agonists |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE231614T1 true ATE231614T1 (de) | 2003-02-15 |
Family
ID=10781868
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT96933513T ATE231614T1 (de) | 1995-10-06 | 1996-10-04 | Screening-test für kalium-kanal agonisten |
Country Status (7)
Country | Link |
---|---|
US (1) | US5837225A (de) |
EP (1) | EP0842427B1 (de) |
AT (1) | ATE231614T1 (de) |
AU (1) | AU7221596A (de) |
DE (1) | DE69625912D1 (de) |
GB (1) | GB9520411D0 (de) |
WO (1) | WO1997014036A1 (de) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9909792D0 (en) | 1998-12-04 | 1999-06-23 | Cambridge Bioclinical Limited | Potassium channel activators and their use |
CN102985065A (zh) | 2010-07-06 | 2013-03-20 | 荷兰联合利华有限公司 | 光甘草宁刺激头发生长的用途 |
CN103002871A (zh) | 2010-07-06 | 2013-03-27 | 荷兰联合利华有限公司 | 锦葵色素用来促进头发生长 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT93337B (pt) * | 1989-03-06 | 1997-01-31 | Univ California | Ensaio para o tratamento e doencas autoimunitarias |
US5620892A (en) * | 1993-09-07 | 1997-04-15 | Bristol-Myers Squibb Company | Strain of Saccharomyces cerevisiae expressing the gene encoding potassium transporter minK |
-
1995
- 1995-10-06 GB GBGB9520411.1A patent/GB9520411D0/en active Pending
-
1996
- 1996-04-05 US US08/628,463 patent/US5837225A/en not_active Expired - Fee Related
- 1996-10-04 AT AT96933513T patent/ATE231614T1/de not_active IP Right Cessation
- 1996-10-04 AU AU72215/96A patent/AU7221596A/en not_active Abandoned
- 1996-10-04 WO PCT/GB1996/002442 patent/WO1997014036A1/en active IP Right Grant
- 1996-10-04 DE DE69625912T patent/DE69625912D1/de not_active Expired - Lifetime
- 1996-10-04 EP EP96933513A patent/EP0842427B1/de not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
WO1997014036A1 (en) | 1997-04-17 |
DE69625912D1 (de) | 2003-02-27 |
AU7221596A (en) | 1997-04-30 |
EP0842427A1 (de) | 1998-05-20 |
GB9520411D0 (en) | 1995-12-06 |
US5837225A (en) | 1998-11-17 |
EP0842427B1 (de) | 2003-01-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2348702B (en) | Antibiotic sensitivity testing | |
DE69011329D1 (de) | Pdgf-alpha-rezeptor. | |
ES8306260A1 (es) | "dispositivo para la determinacion de un analito biologico de interes utilizando agentes fluorescentes encapsulados". | |
CA2304263A1 (en) | Immunoassay method for bnp | |
MXPA99007026A (es) | Metodo para proliferacion y diferenciacion de celulas hematopoieticas y mesenquimatosas. | |
NZ506747A (en) | Screening for blood coagulation defects using metal ions | |
ES2148353T3 (es) | Ensayo para la determinacion de proteina en una muestra biologica. | |
ATE232298T1 (de) | Bioluminenztest für agonisten oder antagonisten eines kalzium-gekuppelten-rezeptors | |
DE60031576D1 (en) | Diagnostisches assay für typ-2-heparin induzierte thrombocytopenie | |
AR018821A1 (es) | Procedimiento para la determinacion de antibioticos con nucleo beta-lactama en un liquido biologico | |
ES2070488T5 (es) | Procedimiento para la diagnosis de enfermedades tumorales. | |
DE69632913D1 (de) | Borathaltige speicherpuffer und probenverdünner | |
BR9406223A (pt) | Método para determinar em uma amostra a atividade funcional de um componente da coagulação sanguinea método para diagnosticar um disturbio da coagulação/anticoagulação sanguinea preparado de anticorpo linhagem celular uso de fator v subunidades ou fragmentos do mesmo tendo atividade anticoagulante na forma de cofator par apc prepraro de plasma embalado plasma deficiente em atividade anticoagulante de fator v como cofator para apc uso do preparado de anticorpo preparado de proteina s preparado de | |
ATE231614T1 (de) | Screening-test für kalium-kanal agonisten | |
DE60015319D1 (de) | Test zur gleichzeitigen messung von verschiedenen enzymatischen aktivitäten | |
WO1999055901A3 (en) | Screening assay for identifying human purinoreceptor ligands | |
Rasmussen et al. | Human thyroid epithelial cells cultured in monolayers. I. Decreased thyroglobulin and cAMP response to TSH in 12-week-old secondary and tertiary cultures | |
AU2394597A (en) | Oxidative metabolism in smooth muscle cells: methods and materials relating thereto | |
DE3680072D1 (de) | Rezeptor-antikoerper-sandwich-untersuchung. | |
DK414386A (da) | Monoklonalt antistof, cellelinje til fremstilling deraf og antistoffets anvendelse | |
ES2121756T3 (es) | Analisis enzimatico y equipo de analisis para medir la activacion celular. | |
Starkey et al. | STOP‐FLOW ANALYSIS OF THE AXONAL TRANSPORT OF DOPA DECARBOXYLASE (EC 4.1. 1.26) IN RABBIT SCIATIC NERVES | |
CA2326713A1 (fr) | Utilisation d'un anticorps specifique des fibroblastes papillaires comme marqueur de qualite d'une peau | |
Mourão et al. | Sulfated glycosaminoglycans synthesized by fibroblast, smooth muscle and endothelium-like cells grown in culture | |
ES8205316A1 (es) | Procedimiento para la determinacion inmunologica de anticuerpos, antigenos y haptenos por efecto comunicador de una ac- tividad enzimatica. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |